N@N

APEI, CODE, BCR, GILD, MET, SCMR, Expected to Trade Lower After Bearish Insider Trading

July 14, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Lower in the next 6 months. AMERICAN PUBLIC EDUCATION, INC. (NASDAQ:APEI), SPANSION INC (NYSE:CODE), C.R. BARD INC (NYSE:BCR), GILEAD SCIENCES, INC. (NASDAQ:GILD), METLIFE, INC. (NYSE:MET), SYCAMORE NETWORKS INC (NASDAQ:SCMR) are all expected to go Lower as Sell signals have been generated by top insider trading patterns. The most important data elements considered when performing insider analysis are: Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns. Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC).

The chart below displays the stocks expected to go Lower along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score.

     Symbol     Company Name                        Insider Name                        Role        Shares         Insider Score     Avg 6 Month Return     # of Dec. 
     APEI       AMERICAN PUBLIC EDUCATION, INC.     Gibbons, Peter W                    O           5,000          90                -10.7%                 6         
     CODE       SPANSION INC                        Nawaz, Ahmed                        O           5,982          97                -62.8%                 22        
     BCR        C.R. BARD INC                       Schermerhorn, Todd C                CFO         20,000         79                -2.9%                  15        
     GILD       GILEAD SCIENCES, INC.               Metza-Anderson, M Kristen           O           5,000          93                -11.6%                 11        
     MET        METLIFE, INC.                       Henrikson, C Robert                 CB          20,000         99                -28.1%                 19        
     SCMR       SYCAMORE NETWORKS INC               Oye, Kevin J                        O           21,166         81                -37.4%                 4         

The insider buying report presents recent insider purchases, reported on Forms 3, 4, and 5 filed with the SEC. The transactions are aggregated to a 'decision' level which simplifies the data analysis. A decision is a grouping of buying or selling by an individual at the specified company.

AMERICAN PUBLIC EDUCATION, INC. (NASDAQ:APEI) - American Public Education, Inc. provides online post secondary education to military and public service communities. It operates through two universities, American Military University and American Public University. The company offers 76 degree programs and 51 certificate programs in various disciplines, such as national security, military studies, intelligence, homeland security, criminal justice, technology, business administration, education, and liberal arts. American Public Education, Inc. serves approximately 63,700 students in the United States, the District of Columbia, and other foreign countries. The company was founded in 1991 and is headquartered in Charles Town, West Virginia.

SPANSION INC (NYSE:CODE) - Spansion Inc., a semiconductor device company, engages in designing, developing, manufacturing, marketing, and selling NOR flash memory solutions worldwide. The companys products are designed primarily to store microprocessor instructions or code and data in embedded applications; and execution is based on NOR Flash memory architecture and utilize traditional floating gate technology or MirrorBit technology. Its flash memory products are used in a range of applications, including automotive electronics, such as navigation systems and engine control; PC and peripheral computing equipment comprising printers; consumer equipment, such as set top boxes and home networking; communication equipment that consists of enterprise networking and cellular infrastructure; arcade gaming equipment; industrial control equipment; and mobile phones. Spansion markets and sells its products directly or through third-party distributors to original equipment manufacturers, original design manufacturers, and contract manufacturers. The company is headquartered in Sunnyvale, California.

C.R. BARD INC (NYSE:BCR) - C. R. Bard, Inc., together with its subsidiaries, engages in the design, manufacture, packaging, distribution, and sale of medical, surgical, diagnostic, and patient care devices worldwide. It offers vascular, urology, oncology, and surgical specialty products. The companys vascular products include percutaneous transluminal angioplasty catheters, guidewires, introducers, and accessories; peripheral vascular stents and stent grafts, vena cava filters, and biopsy devices; electrophysiology products, such as electrophysiology diagnostic, therapeutic, and temporary pacing electrode catheters, as well as laboratory systems; and fabrics, meshes, and implantable vascular grafts. Its urology products comprise infection control Foley catheters to reduce the rate of urinary tract infections; surgical slings used to treat stress urinary incontinence; natural and synthetic devices to treat pelvic floor and vaginal prolapse; brachytherapy services, devices, and radioactive seeds used to treat prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for ureteroscopic procedures and stone removal; fecal incontinence products; and catheter stabilization devices. The company offers various devices to treat and manage cancers, and other diseases and disorders, including specialty access catheters, ports, vascular access ultrasound devices, and enteral feeding devices. Its surgical specialty products include implanted patches and fixation systems for hernia and other soft tissue repairs; irrigation devices for orthopedic, laparoscopic, and gynecological procedures; and products for topical hemostasis. C. R. Bard sells its products directly and through distributors to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. The company was founded in 1907 and is based in Murray Hill, New Jersey.

GILEAD SCIENCES, INC. (NASDAQ:GILD) - Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Its products include Atripla, Truvada, Viread, Emtriva for the treatment of human immunodeficiency virus infection in adults; Hepsera, an oral formulation for the treatment of chronic hepatitis B; AmBisome, a amphotericin B liposome injection to treat invasive fungal infections; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa for the treatment of chronic angina; Vistide, an antiviral medication for the treatment of cytomegalovirus retinitis in patients with AIDS; and Cayston, an inhaled antibiotic used as a treatment to enhance respiratory systems. The companys products also comprise Tamiflu, an oral antiviral for the treatment and prevention of influenza A and B; Macugen, an intravitreal injection for the treatment of neovascular age-related macular degeneration; and Lexiscan/Rapiscan, an injection used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. Its products under the Phase III clinical trials consist of Cobicistat, a pharmacoenhancer that is under evaluation as a boosting agent for HIV medicines; Elvitegravir, an oral integrase inhibitor being evaluated as part of combination therapy for HIV; Integrase Single-Tablet, a Quad regimen of elvitegravir, cobicistat, tenofovir disoproxil fumarate, and emtricitabine for the treatment of HIV/AIDS in treatment-naive patients; and Aztreonam for inhalation solution for the treatment of cystic fibrosis patients with Pseudomonas aeruginosa. The companys Phase II clinical trials products comprise Cicletanine, Ranolazine, and Aztreonam, as well as GS 9190, GS 9256, and GS 9451. Its Phase I clinical trial products include GS 7340, GS 5885, GS 6620, GS 9620, and GS 6624. The company was founded in 1987 and is headquartered in Foster City, California.

METLIFE, INC. (NYSE:MET) - MetLife, Inc., through its subsidiaries, provides insurance, employee benefits, and financial services in the United States, Latin America, the Asia Pacific, Europe, the Middle East, and India. It offers group life insurance products and services as employer-paid benefits, including variable life, universal life, and term life products, as well as employee paid supplemental life products; individual life insurance products and services comprising variable life, universal life, term life, and whole life products, as well as a range of mutual funds and other securities products; and non-medical health insurance products and services, such as dental insurance, group short- and long-term disability, individual disability income, long-term care, critical illness, and accidental death and dismemberment coverages, as well as employer-sponsored auto and homeowners insurance and administrative services-only arrangements to employers. The company also provides retirement products consisting of variable and fixed annuities for individuals and employees of corporations, and other institutions. In addition, MetLife provides an array of annuity and investment products, including guaranteed interest products and other stable value products, income annuities, and separate account contracts for the investment management of defined benefit and defined contribution plan assets, as well as offers certain products to fund postretirement benefits. Further, it offers auto insurance and homeowners insurance policies, as well as personal excess liability and coverage for recreational vehicles and boat owners; and credit insurance and endowment products. Additionally, the company funds company initiatives, various start-up entities, and run-off entities; and banking services, such as residential mortgage loans and various deposit products. The company was founded in 1868 and is based in New York, New York.

SYCAMORE NETWORKS INC (NASDAQ:SCMR) - Sycamore Networks, Inc. develops and markets intelligent bandwidth management solutions for fixed line and mobile network operators worldwide. Its portfolio of optical switches, multiservice cross-connects, and multiservice access platforms serve applications that extend across the network infrastructure from multiservice access and regional backhaul to the optical core. The companys products comprise optical switches, such as SN 16000, SN 3000, and SN 9000 optical switching products that enable bandwidth management in regional and core optical networks; and network-aware management systems and interfaces, including SILVX that empowers comprehensive performance management, in-service scalability, and service delivery without compromising existing systems. It also offers multiservice cross-connect and access products, such as Multiservice Cross-Connects for traffic aggregation and grooming which handle narrowband to broadband switching and transport; Multiservice Access Platforms comprising the IAB-3000 integrated access bank and the SPS-1000 signaling process system that support voice and data integration at end-user sites and in telemetry applications; Access Gateways, including DNX-1u access gateways, which improve site visibility and control; and ENvision Plus network management software that provides provisioning, path protection, and disaster recovery. In addition, the companys product offerings include a portfolio of post-sales customer support services, such as network planning and deployment, logistics, product training, online technical assistance, and maintenance contracts. Sycamore Networks serves domestic and international wireline and wireless network service providers, utility companies, large enterprises, multiple systems operators, and government entities. The company was founded in 1998 and is based in Chelmsford, Massachusetts.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

Insider Trading tracks all insider trades and selects those insider buys that predict higher moves and insider sales that predict lower moves.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net